Rchr
J-GLOBAL ID:200901021898887672   Update date: Mar. 13, 2024

Nakamura Teruya

ナカムラ テルヤ | Nakamura Teruya
Affiliation and department:
Job title: Associate Professor
Research field  (3): Structural biochemistry ,  Biophysics ,  Pharmaceuticals - analytical and physicochemistry
Research keywords  (1): 構造生物学
Research theme for competitive and other funds  (13):
  • 2021 - 2024 基盤研究C
  • 2022 - 2023 2022年度 持田記念研究助成金
  • 2021 - 2022 令和3年度 武田科学振興財団 薬学系研究助成
  • 2020 - 2021 第39回調査研究助成
  • 2018 - 2021 基盤研究(C)
Show all
Papers (37):
  • Teruya Nakamura*, Chiaki Ohyama, Madoka Sakamoto, Tsugumasa Toma, Hiroshi Tateishi, Mihoko Matsuo, Mami Chirifu, Shinji Ikemizu, Hiroshi Morioka, Mikako Fujita, et al. TIFAB regulates the TIFA-TRAF6 signaling pathway involved in innate immunity by forming a heterodimer complex with TIFA. Proceedings of the National Academy of Sciences. 2024. 121. 11
  • Kengo Yasuda, Hitoshi Maeda, Ryo Kinoshita, Yuki Minayoshi, Yuki Mizuta, Yuka Nakamura, Shuhei Imoto, Koji Nishi, Keishi Yamasaki, Mina Sakuragi, et al. Encapsulation of an Antioxidant in Redox-Sensitive Self-Assembled Albumin Nanoparticles for the Treatment of Hepatitis. ACS Nano. 2023
  • Kosei Utatsu, Keiichi Motoyama, Teruya Nakamura, Risako Onodera, Taishi Higashi. Tannic acid-based sustained-release system for protein drugs. International Journal of Pharmaceutics. 2023. 123229-123229
  • Teruya Nakamura*#, Yukari Koga-Ogawa#, Kana Fujimiya, Mami Chirifu, Masataka Goto, Shinji Ikemizu, Yusaku Nakabeppu, Yuriko Yamagata. Protonation states of Asp residues in the human Nudix hydrolase MTH1 contribute to its broad substrate recognition. FEBS Letters. 2023. 597. 1770-1778
  • Toru Taharabaru, Takuya Kihara, Risako Onodera, Tetsuya Kogo, Kenjirou Higashi, Kunikazu Moribe, Teruya Nakamura, Keiichi Motoyama, Taishi Higashi. Polyrotaxane-based multi-step transformable materials for the delivery of Cas9 ribonucleoprotein. Applied Materials Today. 2022. 27. 101488-101488
more...
MISC (15):
  • 中村照也. 動的構造解析による酵素反応機構の解明. DOJIN NEWS. 2023. 187. 11-13
  • Teruya Nakamura. Time-resolved X-ray crystallography of enzymatic reaction that degrades a mutagenic nucleotide. SPring-8/SACLA Research Frontiers 2022. 2023. 28-29
  • 中村照也、小川由香里、山縣ゆり子. ヒトMTH1の幅広い基質認識におけるpH依存性. Photon Factory Activity Report 2023 #41. 2023
  • 中村照也, 山縣ゆり子. 大腸菌MutTによる8-oxo-dGTP加水分解反応の時分割X線結晶構造解析. Photon Factory Activity Report 2022. 2022. #40
  • X-ray crystallographic study on an Fv antibody against GA-pyridine. 2021. #39
more...
Books (2):
  • Protein Modifications in Pathogenic Dysregulation of Signaling
    Signaling, Springer Tokyo 2015
  • 薬学分析科学の最前線
    じほう 2009
Lectures and oral presentations  (89):
  • ヒトMTH1の幅広い基質認識におけるAsp残基のプロトン化状態
    (第96回日本生化学会大会 2023)
  • ヒト酸化ヌクレオチド加水分解酵素による酸化dNTPおよび酸化rNTP認識の構造学的基盤
    (日本薬学会 第143年会 2023)
  • 酵素反応機構の精密解析を目指して
    (第95回日本生化学会大会 2022)
  • Time-resolved X-ray crystallography of E. coli MutT, a Nudix hydrolase
    (2022)
  • DNAの酸化損傷の回避・修復機構の構造学的研究
    (第81回SPring-8 先端利用技術ワークショップ / 大阪大学蛋白質研究所セミナー 2022)
more...
Education (3):
  • 2010 - Ph.D. (Kumamoto University)
  • 2001 - 2003 Osaka University Graduate School of Pharmaceutical Sciences
  • 1997 - 2001 Osaka University School of Pharmaceutical Sciences
Professional career (1):
  • Ph.D. (Kumamoto University)
Work history (9):
  • 2021 - 現在 Kumamoto University Graduate School of Pharmaceutical Sciences Associate Professor (tenured)
  • 2016 - 2021 文部科学省 卓越研究員
  • 2016 - 2021 Kumamoto University Priority Organization for Innovation and Excellence Tenure-Track Associate Professor
  • 2010 - 2016 Kumamoto University Graduate School of Pharmaceutical Sciences Assistant Professor
  • 2011 - 2011 NIH Visiting Scientist
Show all
Committee career (1):
  • 2016 - 2021 放射光構造生物学研究会 幹事
Awards (3):
  • 2013 - 日本結晶学会進歩賞
  • 2013 - 国立大学法人熊本大学研究業績表彰
  • 2012 - 日本生物物理学会若手奨励賞
Association Membership(s) (5):
PROTEIN SCIENCE SOCIETY OF JAPAN ,  THE PHARMACEUTICAL SOCIETY OF JAPAN ,  日本結晶学会 ,  日本生物物理学会 ,  日本生化学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page